Aspergillosis. Clinical forms and treatment;Aspergilosis. Formas clínicas y tratamiento

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 4, 2012, Pages 201-208

  Fortún, Jesús ^a   Meije, Yolanda ^a   Fresco, Gema ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Aspergillosis; Clinical forms; Therapy

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; POSACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; FUNGUS CULTURE; GOLD STANDARD; INVASIVE ASPERGILLOSIS; PROGNOSIS; RADIODIAGNOSIS; TREATMENT INDICATION;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, FUNGAL; ENDOCARDITIS; ENDOPHTHALMITIS; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; NEUROASPERGILLOSIS; POSTOPERATIVE COMPLICATIONS; PULMONARY ASPERGILLOSIS; RISK FACTORS; SALVAGE THERAPY; SPECIES SPECIFICITY; VULNERABLE POPULATIONS;

EID: 84859106862     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.12.005     Document Type: Article

References (55)

1. B.H. Segal Aspergillosis N Engl J Med 360 2009 1870 1884
2. R. Agarwal Allergic bronchopulmonary aspergillosis Chest 135 2009 805 826
3. S.A. Balajee, and K.A. Marr Phenotypic and genotypic identification of human pathogenic aspergilli Future Microbiol 1 2006 435 445
4. C.M. O'Gorman, H.T. Fuller, and P.S. Dyer Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus Nature 457 2009 471 474
5. S. Van Assen, G.P. Bootsma, P.E. Verweij, J.P. Donnelly, and J.M. Raemakers Aspergillus tracheobronchitis after allogeneic bone marrow transplantation Bone Marrow Transplant 26 2000 1131 1132
6. J.A. Sivak-Callcott, N. Livesley, R.A. Nugent, S.L. Rasmussen, P. Saeed, and J. Rootman Localised invasive sino-orbital aspergillosis: characteristic features Br J Ophthalmol 88 2004 681 687 (Pubitemid 38526653)
7. I. El-Hamamsy, N. Dürrrleman, L.M. Stevens, L.P. Perrault, and M. Carrier Aspergillus endocarditis after cardiac surgery Ann Thorac Surg 80 2005 359 364 (Pubitemid 40840257)
8. M. González-Vicent, M.A. Díaz, I. Colmenero, J. Sevilla, and L. Madero Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis Transpl Infect Dis 10 2008 193 196 (Pubitemid 351704009)
9. J. Fortún, J. Carratalá, J. Gavaldá, M. Lizasoain, M. Salavert, R. de la Cámara Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED) Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Update] Enferm Infecc Microbiol Clin 29 2011 435 454
10. C. García-Vidal, A. Upton, K.A. Kirby, and K.A. Marr Epidemiology of invasive mold infections in allogeneic stem-cell transplant recipients: biological risk factors for infection according to time after transplantation Clin Infect Dis 47 2008 1041 1050
11. B. Ferwerda, G. Ferwerda, T.S. Plantinga, J.A. Willment, A.B. van Spriel, and H. Venselaar Human dectin-1 deficiency and mucocutaneous fungal infections N Engl J Med 361 2009 1760 1767
12. P.Y. Bochud, J.W. Chien, K.A. Marr, W.M. Leisenring, A. Upton, and M. Janer Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation New Engl J Med 359 2008 1766 1777
13. P.G. Pappas, B.D. Alexander, D.R. Andes, S. Hadley, C.A. Kauffman, and A. Freifeld Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 2010 1101 1111
14. J. Gavalda, O. Len, R. San Juan, J.M. Aguado, J. Fortun, and C. Lumbreras Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study Clin Infect Dis 41 2005 52 59 (Pubitemid 40863744)
15. J. Fortun, P. Martín-Dávila, S. Moreno, R. Barcena, E. de Vicente, and A. Honrubia Risk factors for invasive aspergillosis in liver transplant recipients Liver Transpl 8 2002 1065 1070 (Pubitemid 35363635)
16. J. Gavaldà, and A. Román Infection in lung transplantation Enferm Infecc Microbiol Clin 25 2007 639 649
17. J. Garnacho-Montero, R. Amaya-Villar, C. Ortiz-Leyba, C. León, F. Álvarez-Lerma, and J. Nolla-Salas Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome Crit Care 9 2005 R191 R199
18. K.H. Vandewoude, S.I. Blot, P. Depuydt, D. Benoit, W. Temmerman, and F. Colardyn Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients Crit Care 10 2006 R31
19. P. Bulpa, A. Dive, and Y. Sibille Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Eur Respir J 30 2007 782 800 (Pubitemid 351194841)
20. J. Lambourne, D. Agranoff, R. Herbrecht, P.F. Troke, A. Buchbinder, and F. Willis Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients Clin Infect Dis 49 2009 1486 1491
21. S. Ascioglu, J.H. Rex, B. de Pauw, J.E. Bennett, J. Bille, and F. Crokaert Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis 34 2002 7 14 (Pubitemid 33152659)
22. B. De Pauw, T.J. Walsh, J.P. Donnelly, D.A. Stevens, J.E. Edwards, and T. Calandra Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813 1821
23. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417 1427
24. J. Fortun, P. Martín-Dávila, M.E. Alvarez, A. Sánchez-Sousa, C. Quereda, E. Navas Ramon y Cajal Hospital's Liver Transplant Group Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients Transplantation 71 2001 145 149 (Pubitemid 32105792)
25. A. Aubry, R. Porcher, J. Bottero, S. Touratier, T. Leblanc, and B. Brethon Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders J Clin Microbiol 44 2006 389 394 (Pubitemid 43222228)
26. J. Fortún, P. Martín-Dávila, M.E. Álvarez, F. Norman, A. Sánchez-Sousa, and L. Gajate False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients Transplantation 87 2009 256 260
27. D.A. Stevens, R.B. Moss, V.P. Kurup, A.P. Knutsen, P. Greenberger, and M.A. Judson Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference Clin Infect Dis 37 Suppl 3 2003 S225 S264
28. S.Y. Park, S.O. Lee, S.H. Choi, J.Y. Jeong, H. Sung, and M.N. Kim Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma Clin Infect Dis 52 2011 e149 e152
29. L. Alcazar-Fuoli, E. Mellado, A. Alastruey-Izquierdo, M. Cuenca-Estrella, and J.L. Rodríguez-Tudela Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification Antimicrob Agents Chemother 52 2008 1244 1251 (Pubitemid 351521983)
30. P.E. Verweij, E. Mellado, and W.J. Melchers Multiple-triazole-resistant aspergillosis N Engl J Med 356 2007 1481 1483
31. E. Snelders, R.A. Huis In't Veld, A.J. Rijs, G.H. Kema, W.J. Melchers, and P.E. Verweij Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles Appl Environ Microbiol 75 2009 4053 4057
32. M.C. Arendrup, E. Mavridou, K.L. Mortensen, E. Snelders, M. Frimodt, and N. Ller Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence PLoS One 5 2010 e10080
33. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
34. R. Herbrecht, D.W. Denning, T.F. Patterson, J.E. Bennett, R.E. Greene, and J.W. Oestmann Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 2002 408 415 (Pubitemid 34851833)
35. O.A. Cornely, J. Maertens, M. Bresnik, R. Ebrahimi, A.J. Ullmann, and E. Bouza Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) Clin Infect Dis 44 2007 1289 1297 (Pubitemid 46717290)
36. C. Viscoli, R. Herbrecht, H. Akan, L. Baila, A. Sonet, and A. Gallamini An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients J Antimicrob Chemother 64 2009 1274 1281
37. R. Herbrecht, J. Maertens, L. Baila, M. Aoun, W. Heinz, and R. Martino Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study Bone Marrow Transplant 45 2010 1227 1233
38. J. Maertens, I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, and F.B. Petrsen Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy Clin Infect Dis 39 2004 1563 1571 (Pubitemid 39578526)
39. T.J. Walsh, I. Raad, T.F. Patterson, P. Chandrasekar, G.R. Donowitz, and R. Graybill Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial Clin Infect Dis 44 2007 2 12 (Pubitemid 44968977)
40. D.P. Kontoyiannis, V. Ratanatharathorn, J.A. Young, J. Raymond, M. Laverdiere, and D.W. Denning Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis Transpl Infect Dis 11 2009 89 93
41. K.A. Marr, M. Boeckh, R.A. Carter, H.W. Kim, and L. Corey Combination antifungal therapy for invasive aspergillosis Clin Infect Dis 39 2004 797 802 (Pubitemid 39244292)
42. N. Singh, A.P. Limaye, G. Forrest, N. Safdar, P. Muñoz, and K. Pursell Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study Transplantation 81 2006 320 326 (Pubitemid 43255714)
43. D. Caillot, T.A. Thiebaut, R. Herbrecht, S. Botton, A. Pigneux, and F. Bernard Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (COMBISTRAT trial) Cancer 110 2007 2740 2746 (Pubitemid 350250344)
44. L. Ostrosky-Zeichner Combination antifungal therapy: a critical review of the evidence Clin Microbiol Infect 14 2008 65 70 (Pubitemid 351593918)
45. S. Schwartz, M. Ruhnke, P. Ribaud, L. Corey, T. Driscoll, and O.A. Cornely Improved outcome in central nervous system aspergillosis, using voriconazole treatment Blood 106 2005 2641 2645 (Pubitemid 41510735)
46. A. Bandera, D. Trabattoni, G. Ferrario, M. Cesari, F. Franzetti, and M. Clerici Interferon-gamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis Infection 36 2008 368 373
47. A.H. Saad, D.D. DePestel, and P.L. Carver Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants Pharmacotherapy 26 2006 1730 1744 (Pubitemid 44885328)
48. A.S. Mathis, N.K. Shah, and G.S. Friedman Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases Transplant Proc 36 2004 2708 2709 (Pubitemid 40036818)
49. C.A. Sable, B.Y. Nguyen, J.A. Chodakewitz, and M.J. DiNubile Safety and tolerability of caspofungin acetate in the treatment of fungal infections Transpl Infect Dis 4 2002 25 30 (Pubitemid 34786821)
50. P.H. Chandrasekar, and J.D. Sobel Micafungin: a new echinocandin Clin Infect Dis 42 2006 1171 1178
51. M.O. Karlsson, I. Lutsar, and P.A. Milligan Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies Antimicrob Agents Chemother 53 2009 935 944
52. T.J. Walsh, I. Lutsar, T. Driscoll, B. Dupont, M. Roden, and P. Ghahramani Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children Pediatr Infect Dis J 21 2002 240 248 (Pubitemid 34214142)
53. D.W. Denning, K. Riniotis, R. Dobrashian, and H. Sambatakou Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review Clin Infect Dis 37 2003 S265 S280
54. P. Lebecque, A. Leonard, and C. Pilette Omalizumab for treatment of ABPA exacerbations in CF patients Pediatr Pulmonol 44 2009 516
55. I. Tillie-Leblond, P. Germaud, C. Leroyer, L. Tetu, F. Girard, and G. Devouassoux Allergic bronchopulmonary aspergillosis and omalizumab Allergy 66 2011 1254 1256